Search for: "Sales v. State"
Results 8201 - 8220
of 21,158
Sorted by Relevance
|
Sort by Date
11 Jul 2022, 4:23 pm
Schmitt v. [read post]
14 Oct 2009, 5:00 am
In Fener v. [read post]
12 Jan 2012, 1:26 pm
Among other cases, the Supreme Courtandrsquo;s majority opinion cited the 1987 case Shearson/American Express Inc. v. [read post]
6 Aug 2018, 8:54 am
Three relevant quotes from SEC v. [read post]
29 Oct 2020, 12:30 pm
Dupart v. [read post]
27 Oct 2013, 9:01 pm
The United States District Court for the Southern District of Ohio recently asked itself the same question (as the title to this article asks) in Wellington Resource Group LLC v. [read post]
6 Jun 2023, 10:27 am
Haas v. [read post]
24 Sep 2009, 10:44 pm
Clement v. [read post]
12 Jun 2012, 2:13 pm
Read the decision, Hogan v. [read post]
12 Jun 2012, 2:13 pm
Read the decision, Hogan v. [read post]
9 Jun 2010, 1:53 pm
--Court: United States District Court for the Southern District of MississippiOpinion Date: 6/1/10Cite: Peavey Electronics Corp. v. [read post]
19 Apr 2019, 3:32 am
Kroma was the licensee of the KROMA marks in the European market, and it alleged that the sales of allegedly infringing beauty products infringed its rights. [read post]
28 Dec 2019, 2:15 am
Case date: 05 December 2019 Case number: No. 18-1363 Court: United States Court of Appeals, Federal Circuit A full summary of this case has been published on Kluwer IP Law. [read post]
23 Jun 2020, 12:56 am
Accordingly, the appellate court vacated the preliminary injunction to the extent that it enjoined the sale of products that the mark owner chose not to buy back, and it remanded the case for reexamination of which product lines were covered by the injunction (Really Good Stuff, LLC v. [read post]
5 Jun 2020, 10:28 am
In Borealis Power Holdings Inc. v. [read post]
24 Aug 2007, 8:03 am
" But in Monsanto Co. v. [read post]
30 Oct 2015, 5:14 pm
[S]ee also Day Zimmermann, Inc. v. [read post]
22 Jun 2017, 10:44 pm
Yang Seyfarth Synopsis: Last month in Mendoza v. [read post]
31 Oct 2017, 12:05 am
Worldwide sales of Copaxone in the year ending 31 December 2016 were about $4.2 billion, representing nearly a fifth of Teva's worldwide sales and a significantly higher percentage of its profits. [read post]
24 Dec 2009, 11:32 am
In re Neurontin Marketing, Sales Practices & Products Liability Litigation, 618 F. [read post]
